Statements (30)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvedBy |
1964
|
| gptkbp:ATCCode |
L01AA03
|
| gptkbp:brand |
gptkb:melphalan
|
| gptkbp:CASNumber |
148-82-3
|
| gptkbp:chemicalClass |
nitrogen mustard
|
| gptkbp:developedBy |
GlaxoSmithKline
|
| gptkbp:form |
gptkb:tablet
powder for injection |
| https://www.w3.org/2000/01/rdf-schema#label |
Alkeran
|
| gptkbp:KEGGID |
D00475
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
antineoplastic agent
|
| gptkbp:MedlinePlusID |
a682220
|
| gptkbp:pregnancyCategory |
D (US)
|
| gptkbp:PubChem_CID |
gptkb:CHEMBL137
DB01042 460612 |
| gptkbp:routeOfAdministration |
oral
intravenous |
| gptkbp:sideEffect |
nausea
vomiting diarrhea hair loss bone marrow suppression |
| gptkbp:UNII |
P1G6Z9A4F5
|
| gptkbp:usedFor |
gptkb:cancer
multiple myeloma |
| gptkbp:bfsParent |
gptkb:melphalan
|
| gptkbp:bfsLayer |
7
|